Curie.Bio
Venture capitalBoston · Seed–Series A · 7 people tracked
Investment thesis
Curie.Bio is a venture capital firm that invests in early-stage biotech therapeutics companies.
Team · 7 people
from the firm's websiteFrequently asked questions
- What stage does Curie.Bio invest at?
- Curie.Bio invests at the Seed, Series A stages.
- What is Curie.Bio's typical check size?
- Curie.Bio typically writes checks of $7M.
- What sectors does Curie.Bio focus on?
- Curie.Bio focuses on Biotech.
- Where is Curie.Bio located?
- Curie.Bio is headquartered in Boston, US.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
a16z is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz that invests in seed through growth-stage technology companies across multiple sectors including AI, healthcare, consumer, crypto, enterprise, fintech, and gaming. The firm manages over $100 billion in assets and operates a distinctive platform model with a large team of operators supporting founders throughout their journey.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Bessemer Venture Partners is a venture capital firm with a 50-year history supporting entrepreneurs in building enduring companies globally. The firm draws on deep operational expertise and advisory relationships to support portfolio companies through their growth journey.
Blume Ventures is a seed and pre-Series A investment firm headquartered in Mumbai that focuses on early-stage companies in India.